通过数学建模方法阐释干扰素-γ和白介素-6的信号交互机制

来源 :中国细胞生物学学会2015年全国学术大会 | 被引量 : 0次 | 上传用户:songtiger2222
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  干扰素-γ (IFN-γ)具有独特的抗病毒活性,能够促进免疫激活,抑制细胞的增殖,诱导细胞凋亡和癌症免疫应答。白介素-6(IL-6)在炎症和免疫应答中同样起到重要的调控作用,能够诱导细胞毒性T淋巴细胞分化、抑制细胞凋亡和增强自然杀伤细胞活性。研究表明,IFN-γ和IL-6信号刺激都可以激活蛋白酪氨酸激酶/信号转导和转录激活因子(JAK/STAT)通路,但它们所激活的STAT蛋白类型是不同的,这与IFN-γ促细胞凋亡而IL-6促细胞增殖的生物学功能直接相关。
其他文献
Histone modifications coordinate the chromatin localization of key regulatory factors in mitosis[1].For example, mitotic phosphorylation of Histone H3 threonine-3 (H3T3ph) by Haspin is required for ce
Apigenin(4,5,7,-trihydroxyflavone) is a common non-mutagenic plant flavonoid widely distributed in vegetables and fruits that has a broad spectrum of anti-proliferative activities against many types o
The Receptor-interacting kinase-3 (RIP3) and its downstream substrate MLKL (mixed lineage kinase domain-like protein) have emerged as the key cellular components in programmed necrotic cell death.
The p2 l-activated kinase 5 (PAK5) is overexpressed in advanced cancer and the transcription factor E47 is a direct repressor of E-cadherin and inducer of epithelial-mesenchymal transition (EMT).
Epithelial-mesenchymal transition (EMT) is a key process in tumor metastatic cascade that is characterized by the loss of cell-cell junctions, resulting in the acquisition of migratory and invasive pr
Lipopolysaccharide (LPS)-induced proliferation of lung fibroblasts is closely correlated with loss of gene expression of thymocyte differentiation antigen-1(Thy-1), accompanied with deacetylation of h
Small cell lung cancer (SCLC) has a strong predilection for brain metastasis.However, the molecular basis is poorly known.Here,we found that the elevated serum levels of annexin A1 in SCLC patients we
Glutaminase C (GAC) is a key metabolic enzyme and play an important role in the glutamine metabolism which was shown to be essential for some cancer cell growth.
As an alternative to genetic changes, epigenetic changes contribute to the aberrant activation of oncogenic signaling in human cancers.
Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) has emerged as a cancer therapeutic agent because of its capability of inducing apoptosis in cancer cells.